Company: BNBX
Filing Date: 2025-01-10
Form Type: S-1/A
Source: 0001104659-25-002521
Chunk: 54

Company: BNB PLUS CORP.
Filing Date: 2025-01-10
Form: S-1/A
Chunk 54
---
 shall not be personally
liable to it or its stockholders for monetary damages for breach of fiduciary duty as a director and that if the Delaware General Corporation
Law is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability
of the registrant’s directors shall be eliminated or limited to the fullest extent permitted by the Delaware General Corporation
Law, as so amended.

As permitted by the Delaware General Corporation
Law, the registrant intends to enter into separate indemnification agreements with each of the registrant’s directors and certain
of the registrant’s officers which require the registrant, among other things, to indemnify them against certain liabilities which
may arise by reason of their status as directors, officers or certain other employees.

The registrant has obtained and maintains insurance
policies under which its directors and officers are insured, within the limits and subject to the limitations of those policies, against
certain expenses in connection with the defense of, and certain liabilities which might be imposed as a result of, actions, suits or
proceedings to which they are parties by reason of being or having been directors or officers. The coverage provided by these policies
may apply whether or not the registrant would have the power to indemnify such person against such liability under the provisions of
the Delaware General Corporation Law.

These indemnification provisions and the indemnification
agreements the registrant intends to enter into between the registrant and the registrant’s officers and directors may be sufficiently
broad to permit indemnification of the registrant’s officers and directors for liabilities (including reimbursement of expenses
incurred) arising under the Securities Act of 1933, as amended.

| Item 15. | Recent Sales of Unregistered Securities |

February 2022 Offering

On February 21, 2022, concurrently with
a registered direct offering of 1,496,400 shares of our Common Stock and/or pre-funded warrants (the “February 2022 Pre-Funded
Warrants”) to an institutional investor (the “February 2022 Purchaser”), we issued to the February 2022 Purchaser
in a private placement (together with the registered direct offering, the “February 2022 Offerings”) unregistered warrants
(“February 2022 Common Warrants”) to purchase up to 1,496,400 shares of Common Stock. Each February 2022 Common
Warrant has an exercise price of $2.84 per share, is exercisable six